中国药学界唯一公开发行的
高等教育研究学术期刊
高级检索

高等医药院校药物临床试验学科教育现状与发展对策

Current Status and Development Strategies of Clinical Drug Trials Education in Chinese Medical and Pharmaceutical Universities

  • 摘要: 随着我国生物医药产业转型升级与科研伦理政策的不断完善,建立系统化、规范化的药物临床试验教育体系已迫在眉睫。然而,当前该领域在高等医药院校中仍面临课程体系散乱、院校发展不均、教育层次覆盖不足、实践平台薄弱等多重问题,制约了高质量研究型人才的有效培养。本文立足国内高校药物临床试验教育的现实基础,系统梳理其发展现状与突出瓶颈,提出以构建标准化课程体系、建立区域协同机制、搭建产教融合平台、完善政策支持体系为路径的对策建议,旨在为推进药物临床试验教育的体系化、规范化发展提供理论支持与实践方向,加快构建具有中国特色、国际接轨的高层次临床研究人才培养体系。

     

    Abstract: With the ongoing transformation and upgrading of China's biopharmaceutical industry and continuous improvement in research ethics policies,establishing a systematic and standardized education system for drug clinical trials has become urgent.However,in this field,higher pharmaceutical institutions still face multiple challenges,including a fragmented curriculum system,uneven development among institutions,insufficient educational coverage,and weak practical platforms,which hinder the effective cultivation of high-quality research talents.Based on the reality of domestic universities' drug clinical research education,this paper systematically reviews the development status and key bottlenecks in the field,and proposes countermeasures focusing on building a standardized curriculum system,establishing regional collaborative mechanisms,creating industry-education integration platforms,and improving policy support systems.The aim is to provide theoretical support and practical directions for advancing the systematic and standardized development of drug clinical trial education and to accelerate the establishment of a high-level clinical research talent cultivation system with Chinese characteristics and international integration.

     

/

返回文章
返回